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Abstract 
 
One of the main challenges in forensic medicine is to estimate the postmortem interval 
(PMI). Several studies regarding postmortem alterations over time in several biological 
matrices such as vitreous humor and cerebrospinal fluid, among others, have addressed 
this major question. However, the obtained results from currently available approaches 
are still unsatisfactory once they have shown no noteworthy changes of the content (e.g. 
electrolytes, cells, etc.) over time after death (low sensitivity), not granting to estimate the 
postmortem interval with high accuracy. 
 
The goal of this study is to evaluate the cellular viability, apoptosis state or necrosis state, 
based on flow cytometry analysis of cells in vitreous humor (VH) and cerebrospinal fluid 
(CSF) collected from human corpses, in order to correlate it with the postmortem interval. 
To this qualitative and quantitative evaluation the probes Annexin V labelled with 
fluorescein and propidium iodide were associated with the trypan blue exclusion test. 
 
In general, CSF presented much higher cellular counts than VH. Therefore, it seems a 
much more appropriate biological matrix for the intended purpose. Cellular density (cell 
counts) showed a tendency to increased values with the increasing of PMI only for CSF 
samples. Also for CSF, a tendency to increased values (from 5.78% to 88.04%) with 
increasing PMI was observed for viable cells. The other tests parameters (“cells of 
interest”, “cellular debris”, percentage of cells in apoptosis or necrosis showed conflicting 
results with each other). 
 
In conclusion, this preliminary study proved that the study of cellular death progression 
present in VH and CSF can be an important strategy to estimate the PMI. However, more 
studies are necessary to definitely prove its value. 
 
Keywords: Cell death; cerebrospinal fluid; flow cytometry; postmortem interval; vitreous 
humor 
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1. Introduction 
 
1.1. Forensic Medicine 
 
The definition of “Forensic Medicine” has been the subject of some discussion. There has 
been some differentiation between the terms “Forensic Medicine” and “Legal Medicine”, 
since for some authors both mean medical knowledge applied to justice, but for others the 
two terms represent different sciences and roles. According to Beran (2010), Legal 
Medicine is more comprehensive than Forensic Medicine, focused on solving legal 
problems in the civil law. Forensic Medicine is the application of biomedical knowledge to 
the resolution of problems in criminal law. Assuming this perspective, this study is related 
with the Forensic Medicine concept. 
 
In a criminal investigation of a death there are three major questions to answer: 1) what 
was the cause of death?; 2) who was involved?; and 3) how long ago did death occur?  
 
The answer to the third question may lead to some clues for the other two, such as the 
possibility of inclusion/exclusion of suspects at the time of death, exclusion of alibis, 
among others (Hayman and Oxenham, 2016; Mathur and Agrawal, 2011). Thus, the 
combination of the subjective evidence, such as witnesses reports, with scientific data can 
help to clarify many situations (Mathur and Agrawal, 2011). 
 
1.2. Postmortem interval 
 
Postmortem interval (PMI) is defined as the time elapsed since the person died until the 
body is discovered and analyzed. It is the answer to question 3): “how long ago did death 
occur?”. As such, one of the main tasks of Forensic Medicine is the determination of this 
period of time (Lee Goff, 2009; Sachdeva et al., 2011). 
After death occurs, several changes begin to happen in the body, not only at a 
macroscopic level, but also at cellular and molecular levels, being autolysis an example 
(Hayman and Oxenham, 2016). The evaluation of these changes help in the 
determination of the time elapsed after the person’s death, i.e., the PMI. Due to physical, 
physicochemical, metabolic and biochemical changes in the human body there are 
several phases that can be analyzed in medical-legal autopsies. These phases 
correspond to a progressive degradation of the body's components, influenced by abiotic 
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(non-living) factors, such as temperature and humidity, along with biotic factors, such as 
the activity of microorganisms (Forbes, 2008; Mathur and Agrawal, 2011). 
 
After the stop of heart beating and circulatory activity there is a period that can last up to 
100-120 minutes (“supravital period”) in which the tissues still respond to stimuli, such as 
the phenomenon of algor mortis, rigor mortis and livor mortis, which allow the estimation 
of a PMI (Hayman and Oxenham, 2016; Mathur and Agrawal, 2011): 
 
 Algor mortis consists in the gradual decrease of the corpse body temperature over 
time. After death, the body ceases to produce heat and the body temperature tends to 
be the same as the surrounding environment (Madea and Kernbach-Wighton, 2013; 
Mathur and Agrawal, 2011). This postmortem phenomenon is used to estimate PMI up 
to 24 hours after death. 
 
 Rigor mortis is a physical and chemical phenomenon that consists in the contraction 
of the body muscles, and begins in the first 2-6h after death, reaching the maximum 
stiffness between 6h and 12h after death. It can remain up to 72 hours, followed by 
muscle relaxation until sagging (Gill-King, 1997; Mathur and Agrawal, 2011). This 
state of contraction is achieved because the body ceases to produce adenosine 
triphosphate (ATP) and reaches an energy level less than 85%, and consequently the 
physiologic calcium flux decreases too (Bate-Smith and Bendall, 1947; Madea and 
Kernbach-Wighton, 2013).  
 
 Livor mortis consists in the deposition of blood in different parts of the body due to 
the gravitational force. These zones acquire a characteristic purple coloration. Despite 
the variability in appearance, it is observed that it can start to occur 15 minutes 
afterdeath, since it happens as soon as the blood circulation stops, but it becomes 
more evident 2 hours after. The livors are well developed after 3h-4h and are fixed 8h-
12h after death (Clark et al., 1997; Mathur and Agrawal, 2011). 
 
According to Vanezis and Trujillo (1996), rigor mortis and livor mortis, like algor mortis, 
must be studied together with other parameters in order to estimate PMI more accurately 
(Madea and Kernbach-Wighton, 2013). The usefulness of this body reactions on the 
estimation of PMI is valid only on the first hours after death and they are not useful when 
the body suffered from burns, for example (Mathur and Agrawal, 2011). Other variables 
can influence the PMI estimation such as climate conditions, body surface, the presence 
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of antemortem pathologies and the age of the individual, among others. Thus, they 
represent rather unspecific parameters in the estimation of PMI because they are 
influenced by many abiotic factors (Hayman and Oxenham, 2016; Kobayashi et al., 2001; 
Krompecher, 1981; Mathur and Agrawal, 2011). 
 
Another parameter useful to estimate PMI is cadaveric putrefaction, which consists in the 
degradation of the soft tissues of the corpse by the action of bacteria and endogenous 
enzymes (autolysis). As a result of the body decomposition, different gases, liquids and 
salts are produced. Cadaveric putrefaction phases can be divided according to the 
postmortem time appearance (Mathur and Agrawal, 2011): 
 
1) Chromatic phase: a green spot appears in the right iliac fossa (abdominal spot), with 
consequent enlargement to the entire abdominal and thoracic wall. At this stage a network 
of superficial veins in the skin can be observed. This stain is propagated through the 
corpse and becomes a blue-greenish hue until it becomes a dark spot (Mathur and 
Agrawal, 2011). This phase appears approximately between 24h and 72h after death, 
depending on the climate conditions; 
 
2) Emphysematous phase: this is the phase where gases already produced by 
putrefaction are released and consequently swell the whole body (Mathur and Agrawal, 
2011). This phase begins between 2 days to 1 week after death; 
 
3) Tissue reduction phase and liquefaction: at this stage there is softening and 
disintegration of the tissues, accumulating putrefied fluids (transudate). Epidermal 
detachment may also occur (Madea and Kernbach-Wighton, 2013; Saukko and Knigth, 
2004). This phase occurs 2-3 weeks after death; 
 
4) Skeletonization phase: in this phase the balance between putrefaction and dehydration 
transforms the transudates into powder (Ubelaker and Zarenko, 2011). This is one of the 
phases that presents more difficulties in the estimation of PMI because of the preservation 
of tissues and the consequent delay in decomposition (Hayman and Oxenham, 2016). 
The time of appearance and duration of this phase depends on the temperature, the 
condition of the corpse (whether buried or not, for instance) and the presence or absence 
of decomposition by microorganisms (Madea and Kernbach-Wighton, 2013). 
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These macroscopic alterations are commonly observed during medical-legal autopsies 
and are helpful in PMI estimation; however, they are not precise and are difficult to 
interpret due to the numerous factors that can influence them. As an example, in the 
different cadaveric putrefaction phases, the autolysis strongly depends on the climatic 
conditions and consequently it can start in an interval between 48h and 72h after death 
(Perper, 2006). 
 
The most important factors that increase the rate of decomposition are: temperature (main 
factor), humidity, the presence of insects and carnivorous animals. On the contrary, 
submersion in water decreases the rate of decomposition (Prieto et al., 2004). 
 
Besides these parameters, there are also cellular and molecular changes that occur in the 
cadaver over time that can help in the determination of PMI. (Hayman and Oxenham, 
2016) described numerous studies that have been carried out based on these changes: 
 
 Biochemical studies: they are based on the analysis of chemical elements/substances 
that are released after death and which accumulate in the body. The main studies 
already performed within this category were based on the evaluation of sodium, 
potassium, hypoxanthine and oxalic acid levels in different biological specimens, such 
as VH and synovial fluid. However, the cited studies presented some limitations, as 
estimation of PMI only 24h after dead, and all of them generally present contradictory 
results; 
 
 Studies of markers in bone marrow and other organs: studies based on the alteration 
of cells or proteins over time. The main studies were performed with cells from bone 
marrow, blood and organs such as heart, and the progression of degradation and 
morphology alteration over time was evaluated. The studies also presented several 
limitations, as inaccuracy in the PMI estimated, the fact that the variability of cellular 
morphology and velocity of changes be too fast to establish a correlation between the 
studied parameter and the PMI, and the influence of abiotic factors; 
 
 Immunohistochemical studies: studies related to the time of response of certain 
components to antigens / antibodies in tissue. These studies are based on the 
biological fluids that contain organic compounds and electrolytes. The main biological 
matrices used for such studies are VH and CSF. However, the studies presented 
some flaws such as the process of autolysis to be too fast in cerebrospinal fluid to 
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study components such as creatinine, insulin, among others and the influence of 
abiotic factors in the results; 
 
 DNA/RNA studies: studies based of an evaluation of the degradation of nucleic acids 
after death. The main biological specimens used are the spleen cells and organs such 
as heart, brain, among others. There are so far no DNA/RNA studies that can be 
applied in the estimation of PMI in routine forensic practice, due to the high 
imprecision, the influence of abiotic factors, the high intra-individual variability, the 
possibility of PMI estimation only after 24 hours after death and the inexistence of 
correlation between the data and the PMI; 
 
 Entomological studies: those involving the study of insects that colonize the body. This 
type of studies needs an in-depth knowledge because the correct identification of 
species and their cycle of reproduction are essential to estimate the PMI, and there is 
a strong influence of abiotic factors. Besides that, this estimation becomes possible 
only 3 to 5 days after death because the colonization starts in this period. However, 
this study is useful for PMIs that are extended to months; 
 
 Studies of bone remains: based on root rings, tendons, ligaments and bones study. 
Both indirect and direct methods exist. The indirect methods involves palynological 
and botanical studies, for example the study of root growth rings around the cadaver, 
but usually results in PMI determinations with high uncertainty. The direct methods 
consist in the morphological examination of the tendons and ligaments that are still 
connected at an early stage of skeletonization. These studies are subjective and 
strongly depend on the investigator experience and knowledge (Hayman and 
Oxenham, 2016). 
 
1.3. Biological matrices 
 
As previously referred, there are several biological matrices that can be studied in order to 
estimate the PMI, for instance, blood, bone marrow, different organs, cerebrospinal fluid, 
vitreous humor and cerebrospinal fluid, among others. 
 
The present study was directed to two biological matrices: vitreous humor (VH) and 
cerebrospinal fluid (CSF) collected from human corpses. Herein these two matrices will be 
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described with regard to their anatomical location, cellular composition and main 
functions. 
 
1.3.1. Vitreous humor 
 
VH is a fluid of gelatinous consistency, representing about 80% of the volume of the eye. 
It is present between the lens and the retina (Figure 1) (Bévalot et al., 2016; Remington, 
2011). The total volume of VH in both eyes may reach 4 mL (Angi et al., 2012; Bévalot et 
al., 2016). 
 
 
 
Figure 1 – Anatomic location of VH in the eye (Purves et al., 2001). 
 
Regarding its composition, VH consists essentially of water, dissolved salts, soluble 
proteins, collagen, hyaluronic acid (HA) and tiny cells – hyalocytes and macrophages 
(Bévalot et al., 2016; Remington, 2011). Hyalocytes represent the major type of VH cells 
(Remington, 2011). 
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The main function of VH is the support and maintenance of the spherical shape of the 
eye. This fluid functions also as a reservoir of metabolites and thus allows the movement 
of these metabolites within the eye (Bévalot et al., 2016; Remington, 2011). 
 
 
1.3.2. Cerebrospinal fluid 
 
CSF is found in the subarachnoid space in the brain (Stratchko et al., 2016). CSF is 
formed by the choroid plexus of the two lateral ventricles, the 3rd and 4th ventricles. Lateral 
ventricle fluid converges in the 3rd ventricle through the foramen of Monro and reaches the 
4th ventricle via the aquaeductus cerebri (Sylvius). The CSF exits from the 4th ventricle 
through the foramina of Magendie and Luschka to the outer surface of the central nervous 
system (CNS) (Damkier et al., 2013) (Figure 2). 
 
The CSF total volume in the body reaches about 90 to 150 mL, distributed in ventricles 
(about 20%), in the subarachnoid space (about 15%) and in spinal cord (Puntis et al., 
2016; Spector et al., 2015; Stratchko et al., 2016). 
 
CSF is composed by epidermal cells, neutrophils, monocytes and lymphocytes (Bardale, 
2009; Johanson et al., 2011; Spector et al., 2015).  
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Figure 2 – Organization of the ventricular system of the brain. The brain parenchyma is shown in 
gray, the ventricles and aquaeductus are in yellow, and the choroid plexus are marked in red 
(Damkier et al., 2013).  
 
Homeostasis in CNS is achieved because there are physical barriers that protect it: the 
blood-spinal cord barrier; the CSF barrier and the blood-brain barrier. These barriers are 
responsible for exchanges between blood and CNS while protecting the parenchyma from 
toxins, invading pathogens and/or cells (Tenreiro et al., 2016). 
 
1.4. Cell death 
 
Historically, cell death study was focused on one form only: the regulated form – 
apoptosis. However, over time other forms of cell death have emerged and have been 
clarified. Currently, cell death can be divided in three different types: apoptosis, 
autophagic cell death and necrosis (Green, 2017), as seen in Figure 3. 
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Figure 3 – Characteristics of the necrosis, apoptosis, and autophagic cell death. Each type of cell 
death has its own morphological and biochemical properties (Escobar-Sánchez et al., 2015). 
 
Apoptosis is an active process that starts when a cell is “marked” for elimination, and this 
pathway is dependent on effector caspases that are hydrolytic enzymes which have the 
role of cleaving substrates, consequently activating apoptosis process (Green, 2017). 
 
The pathway in which apoptosis occurs can be divided in extrinsic, here dead receptors 
are “turned on”, and intrinsic or mitochondrial pathway, in which the mitochondrial 
membrane is permeabilized, releasing proteins that signalize the activation of the 
caspases (Green, 2017), represented in Figure 4. 
 
Cellular alterations include cell wrinkling, organelle damage, coalescence and chromatin 
displacement to the nucleus margins. The structural alterations are divided in two phases: 
the first comprises nuclear and cytoplasmic condensation and the breakage of the cell in 
several conserved fragments that stay next to the plasma membrane, called apoptotic 
bodies; the second comprises phagocytosis of these bodies, which are drawn from the 
epithelial surface or are ingested by other cells, where autolysis occurs within the 
phagosomes and where there is degradation by lysozymes (Kerr et al., 1972). 
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Figure 4 – Intrinsic and extrinsic routes of activation of caspases. Mitochondrial activation involves 
the cytochrome-C delivering from the mitochondria to form a complex composed by the caspase-9 
and the Apaf-1, which in turn will activate the executer caspases -3, -6, or -7. Extrinsic route implies 
the activation of a death receptor in the cytoplasmic membrane by means of a ligand; this process 
will activate the initiator caspase-8, which in turn will activate the executer caspase-3, -6, or -7. The 
activation of the executer caspases provokes the morphological changes related to the apoptotic 
process (Escobar-Sánchez et al., 2015). 
 
Autophagic cell death can result from either apoptosis or necrosis and is a term applied to 
invertebrate systems (e.g. Drosophila) and to a lesser extent in mammalian cell cultures 
(Green, 2017). 
 
Necrosis is a term used by pathologists to refer the presence of dead tissues or cells. It 
represents the changes occurring in the cell after it has already reached equilibrium with 
the surrounding contents (Majno and Joris, 1995), and involves inflammatory 
consequences. 
Unlike apoptosis, necrosis is seen as a passive and accidental process resulting from 
environmental disturbances with uncontrolled release of inflammatory cellular contents. It 
has also been associated with coagulation that is probably the result of an irreversible 
disturbance of the homeostatic mechanisms of the cell (Fink and Cookson, 2005). 
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2. Objectives 
 
This study aimed to find a method to estimate the PMI through the analysis of cellular 
death (apoptosis vs. necrosis) progression of the cells present in two biological matrices 
with different biochemical composition: vitreous humor (of right and left eyeballs) and 
cerebrospinal fluid (from subarachnoid space). 
 
To achieve this goal, this work was divided in two steps: 
 
a) Firstly, cell death evaluation in NC with a vital dye was performed and the FC 
protocol was optimized; 
 
b) Secondly, with all FC parameters duly optimized, the protocol was applied to a set 
of VH and CSF samples collected from human corpses at different times ranging 
from 1h30min to approximately 110h after death in order to look for an eventual 
correlation between PMI and cell death. 
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3. Materials and Methods 
 
3.1. Reagents 
 
The A5-FITC Apoptosis Detection Kit (cat no. 11858777001) and the Trypan blue 0.4% 
solution (cat no. 23850) were purchased from Sigma-Aldrich (St. Louis, USA). 
 
3.2. Samples 
 
Samples were collected in compliance with protocol standards of the National Institute of 
Legal Medicine and Forensic Sciences (INMLCF) - North Branch (Porto), after completing 
all legal formalities, including the signature of a Term of Responsibility by the study author 
(Appendix 1), and obtaining the necessary authorizations (Appendix 2). 
 
After verification of death, the corpses were transported to INMLCF where they were kept 
under refrigeration until autopsy. All sample’s information is presented in Table 1. 
 
Samples of vitreous humor from both right (VH-R) and left (VH-L) eyeballs were collected 
during autopsy with hypodermic puncture needles of 26G 1" 0.45x25 mm and sterile 5 mL 
Luer-Lock™ syringes (BD Medical, Switzerland). 
 
In the first phase of the work the VH from right and left eyeballs were separately collected 
to sterile plastic microtubes. In the second phase of the work, VH from both eyeballs were 
collected to the same sterile Falcon™ tube (BD Biosciences, USA). 
 
Samples of CSF were collected from subarachnoid space with hypodermic puncture 
needles of 22G ½" 0.7x40 mm and sterile 5 mL Luer-Lock™ syringes to sterile plastic 
microtubes. 
 
Samples were immediately placed on ice and transported to the laboratory protected from 
light. 
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Table 1 – Summary of the sample’s information: sample number, gender, age, last time seen alive (date & hour), death verification and 
autopsy (date and hour), cause of death and associated pathologies, when known. Source: INMLCF, I.P. 
1 M 82 11/06/17 | 22h30 12/06/17 | 01h05 13/06/17 | 12h00 Unk Cardiac 
2 F 22 18/06/17 | 20h00 19/06/17 | 14h05 20/06/17 | 16h30 Found hanged Unk 
3 F 41 18/06/17 | 20h00 19/06/17 | 10h40 20/06/17 | 18h00 Found hanged Unk 
4 M 50 25/06/17 | 00h05 25/06/17 | 00h05 26/06/17 | 11h10 Burned Unk 
5 M 58 
30/06/17 | 22h50 
* 
30/06/17 | 22h50 03/07/17 | 11h00 
Liver cirrhosis and 
consumption of toxic 
substances; found in 
CRA 
Unk 
6 F 82 
07/07/17 | 11h10 
* 
07/07/17 | 11h10 10/07/17 | 11h10 Unk Unk 
7 F 50 30/06/17 | 15h00 30/06/17 | 20h00 03/07/17 | 11h00 Voluntary drug intake Unk 
8 F 46 03/07/17 | 00h45 03/07/17 | 1h45 03/07/17 | 16h30 CRA Unk 
9 M 65 01/07/17 | 16h30 01/07/17 | 17h45 03/07/17 | 15h40 Suicide by hanging Unk 
10 M 79 
10/07/17 | 00h20 
* 
10/07/17 | 00h20 10/07/17 | 15h15 Drug intake and CRA Unk 
11 M 62 
12/08/17 | 17h25 
* 
12/08/17 | 17h25 16/08/17 | 11h00 CRA Unk 
12 M 51 
12/08/17 | 22h40 
* 
12/08/17 | 22h40 16/08/17 | 12h00 CRA Unk 
13 M 66 15/08/17 | 21h00 15/08/17 | 21h35 16/08/17 | 16h00 Unk Diabetes 
14 M 66 14/08/17 | 18h00 14/08/17 | 19h00 16/08/17 | 16h30 Unk Arterial hypertension 
15 M 79 
15/08/17 | In the 
morning,36h before 
7h29 
16/08/17 | 19h29 17/08/17 | 16h00 Tried suicide before Unk 
16 M 55 17/08/17 | 19h 17/08/17 | 19h00 18/08/17 | 16h00 CRA Epilepsy / dementia 
17 F 79 
19/08/17 | 08h47 
* 
19/08/17 | 08h47 21/08/17 | 11h30 CRA 
Knees surgery and 
respiratory dysfunction 
CRA – Cardio-respiratory arrest; F – Female; M – Male; Unk – Unknown; * Death at the hospital (so, time of death verification = real time of death). 
  
Sample 
nº 
Gender 
Age 
(years) 
Last time seen alive 
(estimation: day | hour) 
Death 
Verification 
(day | hour) 
Autopsy 
(day | hour) 
Cause of death 
Associated 
pathologies 
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Table 1 – Summary of the sample’s information (cont.). Source: INMLCF, I.P. 
 
CRA – Cardio-respiratory arrest; F – Female; M – Male; Unk – Unknown; * Death at the hospital (so, time of death verification = real time of death). 
  
Sample 
nº 
Gender 
Age 
(years) 
Last time seen alive 
(estimation: day | hour) 
Death 
Verification 
(day | hour) 
Autopsy 
(day | hour) 
Cause of death 
Associated 
pathologies 
18 F 80 
19/08/17 at night 
(considered at 20h) 
20/08/17 | 10h20 21/08/17 | 15h30 Unk Unk 
19 M 43 
19/08/17 at night 
(considered at 20h) 
20/08/17 | 10h55 21/08/17 | 15h30 Unk Psychiatric and alcoholic 
20 F 48 20/08/17 | 22h55 20/08/17 | 23h55 21/08/17 | 15h30 
Liver cirrhosis and 
alcoholism 
Unk 
21 M 85 
22/08/17 | 10h06 
* 
22/08/17 | 10h06 23/08/17 | 11h00 Unk 
Arterial hypertension, 
Obesity, sleep apnoea, 
auricular fibrillation and  
hypertensive heart 
disease 
22 M 54 
Custody death 
22h20 
21/08/17 | 22h20 23/08/17 | 11h30 Metastatic neoplasm Unk 
23 F 83 23/08/17 | 10h00 23/08/17 | 11h00 24/08/17 | 10h00 Hepatic neoplasm Unk 
24 M 63 23/08/17  |  09h26 23/08/17 | 16h26 24/08/17 | 15h30 Hanging Psychiatric 
25 F 28 
23/08/17 
(considered at 12h59 
because death occurred 
at lunch, ca. 3h before) 
23/08/17 | 14h59 24/08/17 | 15h30 Hanging Unk 
26 M 68 
23/08/17 | 15h10 
* 
23/08/17 | 15h10 25/08/17 | 9h30 Unk Psychiatric 
27 M 74 24/08/17 | 14h50 24/08/17 | 15h50 25/08/17 | 15h00 Unk Cardiac 
28 M 50 24/08/17 | 17h00 24/08/17 | 17h45 25/08/17 | 15h00 Unk Psychiatric 
29 M 67 28/08/17 | 08h00 28/08/17 | 09h36 29/08/17 | 10h30 Hanging Unk 
30 M 44 28/08/17 | 20h30 29/08/17 | 14h30 29/08/17 | 16h00 Unk Psychiatric 
31 M 77 
28/08/17 | End of the day 
(assumed at 18h) 
30/08/17 | 08h40 31/08/17 | 15h20 Unk Unk 
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3.3. Cell counting with Neubauer chamber  
 
3.3.1. Total cell count 
 
Total cell counting was performed with Neubauer Chamber (hemocytometer) in an optical 
microscope under the 40x objective. Total cell count included all the viable and nonviable 
cells counted in 4 big squares (Figure 5) of the chamber, each one with a volume of 0,1 
µL. 
To calculate the cellular density the total cell count were divided by total volume (4 x 0,1 
µL), resulting in the following equation: 
 
𝐶𝑒𝑙𝑙𝑢𝑙𝑎𝑟 𝐷𝑒𝑛𝑠𝑖𝑡𝑦 (𝑈/𝑚𝑙) =
(𝑁º 𝑜𝑓 𝑐𝑒𝑙𝑙 𝑐𝑜𝑢𝑛𝑡/4) 𝑥 2 (𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟)
10000
 
 
 
Figure 5 – Counting grid of NC and four of the total nine squares marked in red 
(Ansari et al., 2013). 
 
3.3.2. Trypan Blue exclusion assay 
 
3.3.2.1. Basis of the method 
 
The dye exclusion test is based on the assumption that viable cells have an intact 
membrane and consequently dyes cannot pass through it (Strober, 2001). Trypan blue 
(TB) is a vital stain that gives a blue color to nonviable cells when observed under a 
microscope, while viable cells appear unstained because nonviable cells does not have 
the intact membrane and consequently, they are not able to control the entry of 
macromolecule, letting trypan blue to pass through the cell (Stoddart, 2011). 
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3.3.2.2. Experimental procedure 
 
Cell viability was determined by the TB exclusion assay. Briefly, 20 μL of sample (VH-R, 
VH-L and CSF) were mixed 1:1 with trypan blue 0.4% in a microtube and gently mixed. 
Then, 20 μL of the mixture were loaded into the hemocytometer chamber and the cells 
observed and counted in an optical microscope under the 40x objective, according to the 
manual counting procedure described by Stoddart (2011). This procedure was used for 
subjects no. 1 to 10 (Table 2). 
 
To calculate the percentage of cellular viability, the number of viable cells was divided by 
the total number of cells and multiplied by 100. 
 
𝐶𝑒𝑙𝑙𝑢𝑙𝑎𝑟 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 (%) =
𝑁º 𝑜𝑓 𝑣𝑖𝑎𝑏𝑙𝑒 𝑐𝑒𝑙𝑙 𝑐𝑜𝑢𝑛𝑡 
𝑁º 𝑜𝑓 𝑡𝑜𝑡𝑎𝑙 𝑐𝑒𝑙𝑙 𝑐𝑜𝑢𝑛𝑡
 
 
To calculate the percentage of cellular death, the number of dead cells was divided by the 
total number of cells count and multiplied by 100. 
 
𝐶𝑒𝑙𝑙𝑢𝑙𝑎𝑟 𝑑𝑒𝑎𝑡ℎ (%) =
𝑁º 𝑜𝑓 𝑑𝑒𝑎𝑑 𝑐𝑒𝑙𝑙 𝑐𝑜𝑢𝑛𝑡 
𝑁º 𝑜𝑓 𝑡𝑜𝑡𝑎𝑙 𝑐𝑒𝑙𝑙 𝑐𝑜𝑢𝑛𝑡
 
 
3.4. Flow Cytometry 
 
Flow cytometry (FC) methodology allows to count, examine and classify cells of any type 
(including non-nucleated) in suspension and, since it allows to evaluate these parameters 
simultaneously, it is currently designated by parametric flow cytometry. This technique has 
a five element system: the radiation source, the flow chamber, the optical wavelength filter 
units, the photomultipliers for sensitive detection and signal processing (allowing the 
distinguishing of probes colors used to stain cells) and the data processing unit collecting 
(Brown and Wittwer, 2000; Vermes et al., 2000). 
 
In terms of operation it is based on the source of excitation radiation (in general laser) that 
will intercept the suspended particle in the chamber and this particle undergoes forward 
scattering (FSC) and in the lateral direction [side scattering (SSC)]. This frontal dispersion 
is detected by the photomultipliers and the lateral dispersion is deflected 90° by optical 
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filters and focused on photomultipliers. Frontal dispersion is related to cell size and lateral 
dispersion with internal complexity (e.g., granularity). 
Probes emit radiation too, which associated with a certain internal complexity (SSC) 
provides relevant information as the physiological state of the cell, among others (Brown 
and Wittwer, 2000; Vermes et al., 2000). 
 
3.4.1. A5-FITC and PI binding assay 
 
3.4.1.1. Basis of the method 
 
During the early phase of apoptosis, the intensity of the FSC signal decreases due to cell 
dehydration, and consequent wrinkling. On the contrary, the SSC signal tends to increase 
because the dehydrated cell further reflects and refracts the light. In more advanced 
states of apoptosis the FSC decreases, like SSC, because the cells become smaller, and 
also the ability to reflect and refract light decreases and there are apoptotic bodies being 
formed (Hingorani et al., 2011; Wlodkowic et al., 2011). 
 
Regarding the necrosis state, in the initial phase the primary necrotic cells have the same 
behavior as cells in an advanced phase of apoptosis and apoptotic bodies, and they 
cannot be distinguished from apoptotic cells only by taking into account these two 
parameters (FSC and SSC). These parameters give a general idea of the state of the 
cells present in the sample, but cannot be taken into account as reliable markers. 
However, by combining these FC parameters with the staining with specific dyes it is 
possible to identify and distinguish cells apoptosis and necrosis with less margin of error 
(Hingorani et al., 2011; Wlodkowic et al., 2011). 
 
When attempting to discriminate between apoptosis and necrosis, it is important to know 
their characteristics and to interpret them in their association with the dyes used in the 
analysis. In the case of apoptosis, the fact that cells keep intact their plasma membrane 
until about 4h-6h makes them able to exclude propidium iodide (PI), unlike cells that are in 
the state of cellular necrosis, which allow the dye to enter and to intersperse with DNA 
and RNA (Arends et al., 1990; Hingorani et al., 2011). 
 
A feature that distinguishes cells in apoptosis from viable cells is the presence of the 
phospholipid component phosphatidylserine (PS) exposed on the outer surface of the cell 
membrane, as opposed to what happens in viable cells, where this component is found 
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only on the inner surface of the membrane. This translocation of PS to the external 
surface of the cell membrane is dependent on caspases, according to Fink and Cookson 
(2005). 
 
A5-FITC allows cells to be stained in apoptosis due to its binding to PS, thus 
differentiating viable cells from apoptotic cells (Figure 6). 
 
PI marks the cells in an advanced state of apoptosis and necrosis, allowing to distinguish 
apoptotic cells from necrotic cells when associated with A5-FITC, as shown in Figure 6 
(Hingorani et al., 2011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 – Diagram showing probes for detection of healthy, apoptotic and necrotic cells 
(Hingorani et al., 2011). 
 
3.4.1.2. Experimental procedure 
 
A first step of the work consisted in the optimization of the analytical protocol. Samples 1 
to 10 (Table 2) were used for this preliminary task. 
 
The samples were centrifuged in 1.5 mL plastic microtubes at 22 °C, at 600 g and for 45 
min in the case of VH-R and VH-L and for 15 min in the case of CSF. After centrifugation, 
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the supernatant was aspirated and the pellet was washed with 200 µL of incubation buffer 
from A5-FITC kit and resuspended. For each sample, the cell suspension was divided by 
two plastic microtubes (100 µL in each); one tube was labeled as “stained” and the other 
one as “unstained”. To the “stained” ones, 2 µL of A5-FITC and 2 µL of PI were added. To 
the “unstained” ones the equivalent volume of incubation buffer of the A5-FITC kit was 
added. All samples were incubated for 15 min, protected from light. Afterwards, 500 µL of 
incubation buffer were added to both tubes (“stained” and “unstained”). The content of 
each tube was then totally transferred to cytometry tubes through filtration by FC filters. 
 
The viability parameters, apoptosis and necrosis, were then analyzed by FC. 
 
Fluorescence signals for each sample were collected using an Accuri™ C6 flow cytometer 
(BD Biosciences). To restrict the analysis to cells of interest only, a polygon gate (P1) was 
set according to their light scattering properties (in a forward scatter vs. side scatter plot), 
thus excluding cell debris. To evaluate the % of cell debris among all samples a polygon 
gate (P2) was set according to light scattering properties (in a forward vs. side scatter 
plot) of cell debris. 
 
Fluorescence signals of at least 5,000 and 10,000 cells were acquired for VH-R and VH-L 
and of at least 25,000, 50,000 and 100,000 cells for CSF, both in logarithmic mode, and 
the data were analyzed using the Accuri™ C6 flow cytometer software. The green 
fluorescence due to A5–FITC was followed in channel 1 (FL1) and plotted as a histogram 
of FL1 staining. Fluorescence due to the PI incorporation was followed in channel 3 (FL3). 
 
Samples marked as “unstained” were analyzed before the “stained” ones, acting as 
negative controls. 
 
After this previous evaluation of the procedure, the following changes were made on the 
protocol:  a) VH samples from right and left eyeballs were mixed and analyzed together; 
b) centrifugation was fixed at 600 g for 15 min for all the samples; c) fluorescence signals 
was acquired for 10,000 cells for VH and 100,000 cells for CSF. 
 
b) A5-FITC and PI binding assay 
 
After the establishment of the optimal protocol, samples no. 11 to 31 (n=21) (Table 1) 
were studied in this second phase of the work. 
 20 
Cellular density was calculated by the following equation: 
 
𝐶𝑒𝑙𝑙𝑢𝑙𝑎𝑟 𝐷𝑒𝑛𝑠𝑖𝑡𝑦 (𝑈/𝑚𝐿) =
𝑁º 𝑜𝑓 𝑒𝑣𝑒𝑛𝑡𝑠
𝑣𝑜𝑙𝑢𝑚𝑒 𝑎𝑠𝑝𝑖𝑟𝑎𝑡𝑒𝑑 (𝑚𝑙) 
 
 
To calculate the final percentage of apoptosis and necrosis, determined based on the 
percentage of events in the quadrant Q2-LR (lower right) for apoptosis; and on the 
percentage of events in the quadrant Q2-UR (upper right) for necrosis, of the FL3 (PI 
staining) x FL1 (A5–FITC) channel dot plots, as displayed in Figure 13, the unstained 
samples values were subtracted to those obtained for the stained ones. 
 
3.5. Statistical analysis 
 
Data statistics analysis were performed using GraphPad Prism™ 6.0 (GraphPad 
Software, USA). Comparisons were made using the two-way analysis of variance 
(ANOVA), followed by the Bonferroni's post-hoc test. 
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4. Results 
 
4.1 Protocol optimization 
 
4.1.1. Cellular density 
 
The cellular density (cell counting) was determined by two distinct procedures: Neubauer 
chamber – concomitantly to the TB assay and FC. The results obtained for the tested 
samples (10 individuals = 28 samples: 10 VH-R, 10 VH-L and 8 CSF) during the 
optimization of the analytical protocol are summarized in Table 2. 
 
Table 2 – Cellular density (U/mL) in the tested samples (VH-R, VH-L and CSF) as determined with 
NC and FC. 
NA – Not analyzed (due to contamination with red blood cells). CSF – Cerebrospinal fluid; FC – 
Flow cytometry; NC – Neubauer chamber; PMI – Postmortem interval; VH-L – Vitreous humor from 
left eyeball; VH-R – Vitreous humor from right eyeball. 
  
PMI 
(h) 
Sample 
nº 
Cellular density (U/mL) 
NC FC 
VH-R VH-L CSF VH-R VH-L CSF 
14h45 8 5.00 x10
4
 1.08 x10
6
 1.13 x10
6
 4.16 x10
4
 2.08 x10
6
 1.25 x10
7
 
14h55 10 1.50 x10
5
 4.20 x10
5
 1.02 x10
6
 2.40 x10
4
 6.76 x10
5
 1.25 x10
7
 
26h25 2 7.15 x10
5
 2.40 x10
5
 NA 7.96 x10
4
 1.19 x10
6
 NA 
32h20 3 8.00 x10
4
 4.50 x10
4
 5.95 x10
5
 1.25 x10
7
 8.33 x10
6
 2.50 x10
7
 
34h55 1 1.38 x10
4
 2.75 x10
4
 1.68 x10
5
 4.24 x10
5
 4.63 x10
4
 4.39 x10
5
 
35h05 4 4.75 x10
5
 1.80 x10
5
 4.00 x10
5
 3.01 x10
4
 5.10 x10
5
 3.16 x10
5
 
60h10 5 3.45 x10
5
 2.20 x10
5
 NA 2.08 x10
5
 2.61 x10
4
 NA 
62h00 6 6.40 x10
5
 1.00 x10
5
 5.60 x10
6
 1.47 x10
6
 2.32 x10
4
 7.58 x10
5
 
63h00 7 1.35 x10
5
 2.35 x10
5
 2.86 x10
6
 3.22 x10
4
 6.10 x10
5
 2.50 x10
7
 
69h55 9 9.50 x10
4
 4.30 x10
5
 2.25 x10
5
 1.64 x10
5
 3.57 x10
6
 1.25 x10
6
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Generally, it was observed that cellular density values (number of cells / unit volume) 
determined using the Neubauer chamber procedure were much lower than those obtained 
by FC for the same samples (Table 2). As shown in Figure 7, the difference was 
particularly noticeable for CSF. 
 
 
Figure 7 – Cellular density (U/mL) for VH-R, VH-L and CSF as determined by NC and FC 
procedures. CSF – Cerebrospinal fluid; FC – Flow cytometry; NC – Neubauer chamber; VH-L – 
Vitreous humor from left eyeball; VH-R – Vitreous humor from right eyeball; ** p < 0.05, comparing 
NC and FC methods for CSF cellular density. The values are given as the mean ± SEM (n = 10). 
 
Table 2 data and Figure 7 also show that CSF presented a much higher cellular density 
than both VH-R and VH-L. 
 
In what concerns the correlation with PMI, it was not possible to perceive a clear pattern 
of variation of cellular density over time. For NC data, it was observed a fluctuation of the 
results for VH-R from 5x104 U/mL for PMI = 14h45, to 9,50x104 U/mL for PMI = 69h55, 
with the maximum value of cellular density (7,15x105 U/mL) for PMI = 26h25; and for CSF 
from 1,13x106 U/mL for PMI = 14h45 to 2,25x105 U/mL for PMI = 69h55, with the 
maximum value of 5.60x106 U/mL for PMI = 62 h. The same fluctuant behavior was 
observed for FC data for all matrices: in VH-R the values varied from 4,16x104 U/mL for 
PMI = 14h45 to 1,64x105 U/mL for PMI = 69h55, with the maximum value of 1,25x107 
U/mL for PMI = 32h20 h; in VH-L varied from 2,08x106 U/mL for PMI = 14h45 to 3,57x106 
U/mL for PMI = 69h55, with the maximum of 8,33x106 U/mL for PMI = 32h20; and in CSF 
varied from 1,25x107 U/mL for PMI = 14h45 to 1,25x106 U/mL for PMI = 69h55, with the 
maximum of 2,50x107 U/mL for PMIs = 32h20 and 63 h. 
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4.1.2. Cellular viability 
 
The results obtained for the cellular viability for all the tested samples during protocol 
optimization (n = 30 samples; 10 VH-R, 10 VH-L and 8 CSF) with both the TB assay (with 
NC cell counting) and FC are summarized in Table 3. 
 
Table 3 – Cellular viability (%) for VH-R, VH-L and CSF as determined by TB assay and FC. 
PMI (h) 
Sample 
nº 
Cellular viability (%) 
TB FC 
VH-R VH-L CSF VH-R VH-L CSF 
14h45 8 0.00 31.16 82.22 0.00 31.16 82.22 
14h55 10 13.33 0.00 89.71 13.33 0.00 89.71 
26h25 2 5.59 37.50 NA 5.59 37.50 NA 
32h20 3 37.50 100.00 41.18 37.50 100.00 41.18 
34h55 1 52.92 67.86 51.40 52.92 67.86 51.40 
35h05 4 48.42 16.67 23.75 48.42 16.67 23.75 
60h10 5 15.94 6.82 NA 15.94 6.82 NA 
62h00 6 13.28 15.00 87.67 13.28 15.00 87.67 
63h00 7 62.96 40.43 91.26 62.96 40.43 91.26 
69h55 9 10.53 46.51 80.00 10.53 46.51 80.00 
NA – Not analyzed (due to contamination with red blood cells). CSF – Cerebrospinal fluid; FC – 
Flow cytometry; PMI – Postmortem interval; TB – Trypan blue assay (with Neubauer chamber cell 
counting); VH-L – Vitreous humor from left eyeball; VH-R – Vitreous humor from right eyeball. 
 
Generally, it was observed that cellular viability values determined by the TB assay were 
quite similar to those obtained by FC (Table 3 and Fig. 8). 
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Figure 8 – Cellular viability (%) in VH-R, VH-L and CSF as determined by NC and FC procedures. 
CSF – Cerebrospinal fluid; FC – Flow cytometry; TB – Trypan blue assay ((with Neubauer chamber 
cell counting); VH-L – Vitreous humor from left eyeball; VH-R – Vitreous humor from right eyeball; 
** p < 0.05, comparing NC and FC procedures for CSF cellular density. The values are given as the 
mean ± SEM (n = 10).  
 
Table 3 and Figure 8 also clearly show that CSF presented higher levels of cellular 
viability than VH-R and VH-L, as evaluated by both NC-TP and FC procedures. 
 
4.2 Samples analysis 
 
After this initial study on methodological aspects, FC was selected to continue the work. 
Also, due to their low cell count, it was decided to mix the VH samples from left and right 
eyeballs of the same individual to increase the final sample volume. The work continued 
with the analysis of n=21 VH samples and n=17 CSF samples (4 CSF samples were 
excluded due to contamination with red blood cells), and the following parameters were 
studied: i) cellular density; ii) cells of interest and cellular debris; iii) cellular viability, and 
iv) apoptosis and necrosis. The results are presented below. 
 
i) Cellular density 
 
The cell counting values (U/mL) versus PMI for both VH and CSF samples are depicted in 
Figure 9. As observed, a poor correlation between variables was obtained, especially in 
VH samples. 
 
Figure 9 – Relationship between cellular density (U/mL) and PMI for both VH and CSF samples. 
 
ii) Cells of interest and cellular debris 
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Representative dot plots of FC analysis of two samples [a) VH sample no. 24; b) CSF 
sample no. 20] are depicted in Figure 10. 
 
The “cells of interest” and the “cellular debris” were defined, according to their size and 
complexity, through the polygon gates P1 and P2, respectively (drawn in red in the SSC 
vs. FSC dot plots shown in Figure 10). 
 
 
Figure 10 – Representative FC dot plots of SSC (Y-axis) and FSC (X-axis) parameters for a VH (a) 
and a CSF (b) samples. 
 
For VH samples, the results obtained (P1 – cells of interest and P2 – cellular debris 
percentages) were related to the correspondent PMI as shown in Figure 11. 
 
 
Figure 11 – Relationship between the parameter %P1 (cells of interest), %P2 (cellular debris) and 
PMI for VH samples. 
 
a) b) 
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The values of %P1 for VH samples (Figure 11, left) varied from a minimum of 8.87% for 
PMI = 28h35 to a maximum of 57.76% for PMI = 66h20.  
The values of %P2 for VH samples (Figure 11, right) varied from a minimum of 37.76% at 
PMI = 24h31 to a maximum of 88.32% at PMI = 28h35.  
The data showed a random scatter not dependent on PMI. 
 
A similar graphic representation of the results obtained for CSF samples (P1 – cells of 
interest; P2 – cellular debris percentages) as a function of PMI is depicted in Figure 12. 
 
 
Figure 12 – Relationship between the parameter %P1 (cells of interest), %P2 (cellular debris) and 
PMI for CSF samples. 
 
The most interesting finding is the quite similar data pattern between CSF and VH. Again, 
the %P1 values showed a clear tendency for increased cell levels with increased PMI (in 
the range 20-70 hours), and %P2 values showed an inverse relation with increased PMI 
(in the range 20-70 hours), in comparison with %P1. However, CSF samples presented a 
much higher %P1 (cells of interest) and lower %P2 (cellular debris) than VH. 
 
iii) Cellular viability  
 
The percentage of viable cells in CSF and VH samples was determined based on the 
percentage of events at quadrants Q1-LL or Q2-LL (lower left) in FL3 x FL1 dot plots (as 
displayed in Figure 14). 
 
The relationship between the obtained data and PMI is shown on Figure 13. 
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Figure 13 – Cellular viability (%) in VH and CSF samples as a function of PMI. 
 
The percentage of viable cells in VH ranged from a minimum of 5.78% from PMI = 23h10 
to a maximum of 88.04% for PMI = 66h20. The percentage of viable cells in CSF ranged 
from a minimum of 30.15% for PMI = 45h to a maximum of 93.71% for PMI = 45h15. 
Average cellular viability was much higher in CSF samples. In both cases, a tendency to 
increase between this parameter and PMI was observed.  
 
iv) Apoptosis and Necrosis 
 
As referred before, the percentage of apoptotic and necrotic cells was determined based 
on the percentage of events in the quadrant Q2-LR (lower right) for apoptosis; and on the 
percentage of events in the quadrant Q2-UR (upper right) for necrosis, of the FL3 (PI 
staining) x FL1 (A5–FITC) channel dot plots, as displayed in Figure 14. 
  
Figure 14 – Representative FC dot plots of FL3 (PI staining) and FL1 (A5–FITC staining) channel 
signal displaying the percentage of apoptosis (LR quadrants) and necrosis (UR quadrants) for both 
matrices: VH (a) and CSF (b). 
 
a) b) 
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a) Apoptosis 
The percentage of apoptosis in VH (Figure 15, left) varied from a minimum of 7.10% for 
PMI = 47h04 to a maximum of 92.98% for PMI = 23h10. In CSF the percentage of 
apoptosis was somewhat lower (Figure 15, right). The percentage varied from a minimum 
of 3.91% for PMI = 47h04 to a maximum of 65.33% for PMI = 45h. 
A tendency for increasing values with PMI was observed for VH samples but not for CSF, 
where the tendency was to decrease along PMI. 
 
 
Figure 15 – Percentage of apoptotic cells in VH and CSF samples as a function of PMI. 
 
b) Necrosis 
The percentage of necrotic cells in VH and CSF samples are depicted in Figure 16. For 
VH (Figure 16, left) the values ranged from 0% for PMI = 23h10 to a maximum of 71.03% 
for PMI = 47h04. The highest values were found for PMI between 20-50 h, but no 
correlation with PMI was observed. In CSF (Figure 16, right) the percentage of necrosis 
was significantly lower (maximum of 14.38%), even at high PMI values (<15%), but an 
even random data scatter was observed. 
 
Figure 16 – Percentage of necrotic cells in VH and CSF samples as a function of PMI. 
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5. Discussion and Conclusions 
 
In criminal investigation, PMI is an important parameter to be determined and a lot of 
studies have been performed to achieve this goal, such as biochemical studies of markers 
in bone marrow and other organs (which may be cells or proteins), immunohistochemical, 
with DNA/RNA, entomological and in bone remains, as reviewed by Hayman and 
Oxenham (2016). However, and according to our knowledge, no one has developed a 
sufficient accurate method to be used in daily forensic routine. Therefore, the pursuing to 
new methods and studies continues to be of paramount interest in this field. 
 
Bardale (2009) performed a study with CSF to evaluate the alterations on the cells 
present in this matrix over time. The author concluded that the number of cells in this 
biological fluid increases over time after death and that up to 12 hours it was possible to 
identify the presence of different cell types, such as lymphocytes, neutrophils and 
monocytes, but after this period the identification / classification becomes very difficult. It 
should be noted that the samples used in the abovementioned work were collected by 
cisternal puncture, and from brain ventricles, and this may justify some differences 
regarding total cell counts. 
 
In the present work two different biologic matrices, VH and CSF, collected from human 
corpses during autopsy procedures were studied. The main reasons to choose these 
matrices were: its anatomical location – more protected from decomposition than for e.g. 
blood samples and organs in general; no special sample pretreatment required; the 
different biochemical composition of each one (thus eventually allowing to obtain different 
information from each one); the fact that they are commonly used in other studies; and 
finally the fact they are easy to collect in medical autopsies. 
 
The main objective of this study, as referred before, was to evaluate if PMI could be 
estimated through the analysis of cell death progression in the cells present in two 
biological matrices with different biochemical composition: VH and CSF. Different 
parameters were studied, such as cellular density and viability, apoptosis and necrosis. To 
achieve this goal, TB exclusion assay (with cell counting in Neubauer chamber under 
optical microscopy) and a FC approach using PI and A5–FITC staining were used. 
 
TB exclusion test is an inexpensive method and does not require special equipment. It 
enables to obtain both quantitative and qualitative results and a quite convenient 
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evaluation of cell death progression that can help in the study of body’s decomposition 
level. However, this procedure is time consuming and strongly depends on the 
investigator’ knowledge and experience, making it subjective and poorly accurate. 
 
On the contrary, FC requires specialized equipment to perform the analysis and it is faster 
to run the samples (it can count about 1000 to 10000 cells per second), thus being the 
technique of choice for the study of a large number of samples (Darzynkiewicz et al., 
1997; Ferlini et al., 1997; Koopman et al., 1994; Schmid et al., 1994). Furthermore, for this 
specific study, one of the major advantages of FC is that through the analysis of a single 
sample it is possible to evaluate cellular density and viability, apoptosis and necrosis 
(instead of just cellular viability and unspecific death as in TB exclusion assay and cell 
counting under optical microscopy) and the simplicity of the procedure. However, FC has 
the disadvantage that it is not often possible to distinguish individual cells from cell 
aggregates. 
 
Due to the advantages mentioned above, after the optimization step of the work, FC was 
elected to proceed the study. 
 
For A5-FITC and PI binding assay, the individually collected VH-R and VH-L samples 
were mixed in a same plastic microtube in order to increase cell concentration and 
consequently a higher number of events in FC analysis. It is important to note that during 
the optimization of the procedure no statistically significant difference (p >0.05) was 
observed between the results obtained for cellular density and viability in the two eyeballs 
samples, nor for TB exclusion assay neither for FC analysis (cf. Table 2 and Figure 6). 
 
Generally, CSF presented much higher cellular counts than both VH-R and VH-L. 
Therefore, CSF seems to be a much more appropriate biological matrix for this kind of 
studies. 
 
As referred above, the main study (n=21 samples of VH and n=17 samples of CSF) was 
conducted using only FC. A flow cytometric approach using PI and A5–FITC staining was 
used. 
 
Regarding cellular density it seems to exist a tendency to increased values with PMI 
observed for CSF, which is in accordance with a previous study from Bardale (2009). 
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Regarding “cells of interest” (P1) and “cellular debris” (P2), no conclusions can be drawn. 
An inverse relationship was expected between these parameters because they are 
complementary. For VH samples there was no direct relationship with PMI neither for P1 
nor for P2, but P2 percentages were much higher than P1 in this matrix. For CSF samples 
(Figure 12), an inverse relationship between “cells of interest” (P1) and “cellular debris” 
(P2) was observed. P1 tended to increase with PMI, and according to Bardale (2009), this 
may be due to the migration of cells to CSF during the first hours after death. 
 
The % of cellular viability in VH seemed to increase but in two parallel lines, reflecting a 
great inter-individual variability. Therefore a common model cannot be assumed. For CSF 
this tendency to increased values with PMI was also observed, with a higher correlation 
coefficient (Figure 13). 
 
The parameter % apoptosis showed a conflicting tendency (to decrease with PMI in CSF 
and to increase in VH). The % necrosis showed no tendency for both matrices. The data 
were random scatter with no relationship to PMI. 
 
 
In summary, this study showed that the flow cytometric approach used (involving PI and 
A5–FITC staining) has potential to generate important information regarding cellular 
changes after death. However, no direct correlation was found between any of the 
parameters tested (related to progression of cell death) and PMI. 
 
The present work has as major limitation which is the absence of an exact knowledge of 
the PMI of each individual studied (because of the absence of exact information about the 
time at which the dead occurred). So, this study needs to be continued in order to 
increase the number of analyzed individuals and to extend the range of PMI studied. 
 
In future works it is important to consider the possibility of study individuals who died at 
hospitals, in controlled environmental conditions which would allow more accurate time of 
dead determination. 
Looking to the literature, this study was pioneer in using FC analysis to evaluate the 
progression of cell death overtime in VH and CSF in order to use this approach in the 
future to estimate PMI. 
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